Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMCITABINE for Diffuse large b-cell lymphoma stage i: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where GEMCITABINE was used for Diffuse large b-cell lymphoma stage i.

Most Reported Side Effects for GEMCITABINE

Side Effect Reports % Deaths Hosp.
Off label use 3,319 10.6% 496 1,162
Disease progression 3,123 10.0% 558 411
Thrombocytopenia 2,320 7.4% 271 875
Drug ineffective 2,003 6.4% 486 431
Malignant neoplasm progression 1,962 6.3% 602 411
Neutropenia 1,892 6.0% 235 512
Anaemia 1,745 5.6% 223 820
Pyrexia 1,511 4.8% 148 1,102
Nausea 1,336 4.3% 146 650
Myelosuppression 1,197 3.8% 50 559
Fatigue 1,098 3.5% 124 440
Febrile neutropenia 1,082 3.5% 264 653
Diarrhoea 1,074 3.4% 179 603
Vomiting 1,016 3.2% 116 645
Neoplasm progression 960 3.1% 239 175

Other Indications for GEMCITABINE

Pancreatic carcinoma (2,706) Diffuse large b-cell lymphoma (2,506) Product used for unknown indication (2,401) Pancreatic carcinoma metastatic (1,586) Cholangiocarcinoma (1,181) Adenocarcinoma pancreas (1,089) Bladder cancer (841) Transitional cell carcinoma (825) Ovarian cancer (648) Non-small cell lung cancer (634)

Other Drugs Used for Diffuse large b-cell lymphoma stage i

RITUXIMAB (134) CYCLOPHOSPHAMIDE (112) DOXORUBICIN (102) VINCRISTINE (98) PREDNISONE (68) EPCORITAMAB (59) PREDNISOLONE (33) ETOPOSIDE (27) IFOSFAMIDE (17) CARBOPLATIN (16)

Related Pages

GEMCITABINE Full Profile All Diffuse large b-cell lymphoma stage i Drugs GEMCITABINE Demographics GEMCITABINE Timeline